|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00445380 |
Purpose
RATIONALE: An education session using a board game or workbook may increase a young donor's knowledge about stem cell transplant. It may also reduce a donor's anxiety about the procedure.
PURPOSE: This clinical trial is studying education sessions to see how well they increase knowledge and reduce anxiety in young first degree relative stem cell donors.
| Condition | Intervention |
|---|---|
|
Cancer |
Other: counseling intervention Other: educational intervention Procedure: psychosocial assessment and care |
| Study Type: | Interventional |
| Official Title: | Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures |
| Estimated Enrollment: | 20 |
| Study Start Date: | December 2006 |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a pilot study. Participants are stratified by age (10-15 years of age vs 16-26 years of age).
Participants attend an educational session comprising a board game intervention (ShopTalk) (for participants 10-15 years of age) or a workbook intervention (for participants 16-26 years of age).
Participants take a knowledge-assessment quiz at baseline, 24 hours before and after educational session, and 1 month after educational session. Participants also complete a written anxiety assessment at baseline, 24 hours before educational session, and 1 month after educational session.
PROJECTED ACCRUAL: A total of 20 participants will be accrued for this study.
Eligibility| Ages Eligible for Study: | 10 Years to 26 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, Maryland | |
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting |
| Bethesda, Maryland, United States, 20892-1182 | |
| Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937 | |
| Principal Investigator: | Lori Wiener, PhD | NCI - Pediatric Oncology Branch |
More Information
| ClinicalTrials.gov Identifier: | NCT00445380 History of Changes |
| Other Study ID Numbers: | 070086, CDR0000534409, NCI-07-C-0086 |
| Study First Received: | March 7, 2007 |
| Last Updated: | September 29, 2011 |
| Health Authority: | Unspecified |
|
psychosocial effects of cancer and its treatment adult acute myeloid leukemia with 11q23 (MLL) abnormalities adult acute myeloid leukemia with inv(16)(p13;q22) adult acute myeloid leukemia with t(15;17)(q22;q12) adult acute myeloid leukemia with t(16;16)(p13;q22) adult acute myeloid leukemia with t(8;21)(q22;q22) accelerated phase chronic myelogenous leukemia adult acute lymphoblastic leukemia in remission adult acute myeloid leukemia in remission atypical chronic myeloid leukemia, BCR-ABL1 negative blastic phase chronic myelogenous leukemia childhood acute lymphoblastic leukemia in remission childhood acute myeloid leukemia in remission childhood chronic myelogenous leukemia chronic eosinophilic leukemia |
primary myelofibrosis chronic myelomonocytic leukemia chronic neutrophilic leukemia chronic phase chronic myelogenous leukemia de novo myelodysplastic syndromes disseminated neuroblastoma extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue juvenile myelomonocytic leukemia myelodysplastic/myeloproliferative neoplasm, unclassifiable nodal marginal zone B-cell lymphoma noncontiguous stage II adult Burkitt lymphoma noncontiguous stage II adult diffuse large cell lymphoma noncontiguous stage II adult diffuse mixed cell lymphoma noncontiguous stage II adult diffuse small cleaved cell lymphoma noncontiguous stage II adult immunoblastic large cell lymphoma |
|
Lymphoma, Non-Hodgkin Lymphoma, Large-Cell, Immunoblastic Lymphoma Neoplasms by Histologic Type Neoplasms |
Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases |